Tenapanor market price reference and purchasing methods
Tenapanor (tenapanor) is a drug used in patients with chronic kidney disease and hyperphosphatemia. It mainly reduces blood phosphorus levels by inhibiting the intestinal sodium/phosphorus co-transporter. This drug is already on the market in China and is covered by medical insurance. For specific prices, please consult the local hospital pharmacy and obtain it mainly through regular hospitals or authorized pharmacies. Before purchasing, it is recommended that patients consult their attending doctor or hospital pharmacy to ensure that the medicine is from a regular source and is safe and reliable to use.
Compared with the prices of overseas original drugs, if domestic patients obtain them through formal import channels or specific hospitals, the cost may be relatively high. The price of each box of overseas original drugs is about more than 3,000 US dollars, which is a relatively high amount in RMB. This also reflects that the economic cost of this drug is relatively high, and patients need to plan their treatment budget in advance.
In overseas markets, in addition to the original drug, generic versions of Tenapano are already on the market, such as the generic version produced by Lucius in Laos. 30mg*14 tablets are priced at about 600 RMB per box. The generic drug has basically the same ingredients as the original drug and can be used as an economically viable alternative. For domestic patients, if they obtain it through formal cross-border medical or authorized import channels, the cost of treatment can also be reduced, but they must pay attention to compliance with relevant regulations and safety of use.
Generally speaking, the purchase of Tenapano in China mainly relies on regular hospitals and authorized pharmacies, but the price is high. Overseas original drugs are more expensive, but generic drugs provide a relatively economical option. During use, you should strictly follow the doctor's instructions to ensure reasonable dosage and medication safety, and combine it with regular blood phosphorus monitoring and lifestyle intervention to achieve the best therapeutic effect.
Reference materials:https://pubmed.ncbi.nlm.nih.gov/29563740/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)